Sensory Distribution of Lateral Femoral Cutaneous Nerve Block

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate and describe the anatomical distribution of the sensory outcome following LFCN block (LFCN = lateral femoral cutaneous nerve) in relation to the incisional lines after Total Hip Arthroplasty (THA). Furthermore, is the aim to examine whether there is a motorial outcome corresponding to the Femoral nerve. The trial will be conducted in healthy volunteers in a blinded, randomized paired study.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Zealand University Hospital
• Collaborator: Naestved Hospital
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Participants who have given their written consent after understanding the content and limitations og the study.

• ASA 1-2.

• BMI ≥18 and ≤ 30

Exclusion Criteria:

• Participants who can not cooperate in the study.

• Participant who can not speak or understand danish.

• Allergies to the drugs used in the study.

• Alcohol consumption that exceeds 21 units per week.

• Drug abuse by the investigators judgement.

• Daily consumption of prescription required analgesic drugs within the last four weeks.

• Consumption of over the counter analgesic drugs within the last 48 hours.

• Neuromuscular defects, former surgery or trauma to the lower extremities.

• Diabetes mellitus.

• Pregnant women (women in the fertile age must have used safe contraception and test negative with a urine-HCG to be able to participate in the study).